Leukemogenic Ptpn11 Allele Causes Defective Erythropoiesis in Mice

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2014 Oct 8

PMID 25289670

Citations 6

Authors

Tatiana Usenko

Gordon Chan

Emina Torlakovic

Ursula Klingmuller

Benjamin G Neel

Affiliations

Soon will be listed here.

Abstract

Src homology 2 (SH2) domain-containing phosphatase 2 (SHP2), encoded by PTPN11, regulates signaling networks and cell fate in many tissues. Expression of oncogenic PTPN11 in the hematopoietic compartment causes myeloproliferative neoplasm (MPN) in humans and mice. However, the stage-specific effect(s) of mutant Ptpn11 on erythroid development have remained unknown. We found that expression of an activated, leukemogenic Ptpn11 allele, Ptpn11D61Y, specifically in the erythroid lineage causes dyserythropoiesis in mice. Ptpn11D61Y progenitors produce excess cKIT+ CD71+ Ter119- cells and aberrant numbers of cKITl° CD71+ erythroblasts. Mutant erythroblasts show elevated activation of ERK, AKT and STAT3 in response to EPO stimulation, and MEK inhibitor treatment blocks Ptpn11D61Y-evoked erythroid hyperproliferation in vitro. Thus, the expression of oncogenic Ptpn11 causes dyserythropoiesis in a cell-autonomous manner in vivo.

Citing Articles

Oncogenic and microenvironmental signals drive cell type specific apoptosis resistance in juvenile myelomonocytic leukemia.

Koleci N, Wu Y, Wehner N, Rajak J, Mittapalli V, Mergner J Cell Death Dis. 2025; 16(1):165.

PMID: 40057493 PMC: 11890777. DOI: 10.1038/s41419-025-07479-2.

Erythroid-specific inactivation of Slc12a6/Kcc3 by EpoR promoter-driven Cre expression reduces K-Cl cotransport activity in mouse erythrocytes.

Shmukler B, Rivera A, Nishimura K, Hsu A, Wohlgemuth J, Dlott J Physiol Rep. 2022; 10(5):e15186.

PMID: 35274823 PMC: 8915159. DOI: 10.14814/phy2.15186.

SHP2-Mediated Signal Networks in Stem Cell Homeostasis and Dysfunction.

Kan C, Yang F, Wang S Stem Cells Int. 2018; 2018:8351374.

PMID: 29983715 PMC: 6015663. DOI: 10.1155/2018/8351374.

Role of SHP2 in hematopoiesis and leukemogenesis.

Pandey R, Saxena M, Kapur R Curr Opin Hematol. 2017; 24(4):307-313.

PMID: 28306669 PMC: 5709049. DOI: 10.1097/MOH.0000000000000345.

Governing roles for Trib3 pseudokinase during stress erythropoiesis.

Dev A, Asch R, Jachimowicz E, Rainville N, Johnson A, Greenfest-Allen E Exp Hematol. 2017; 49:48-55.e5.

PMID: 28062363 PMC: 5393943. DOI: 10.1016/j.exphem.2016.12.010.

References

Vegiopoulos A, Garcia P, Emambokus N, Frampton J . Coordination of erythropoiesis by the transcription factor c-Myb. Blood. 2006; 107(12):4703-10. PMC: 1895806. DOI: 10.1182/blood-2005-07-2968. View

Heinrich A, Pelanda R, Klingmuller U . A mouse model for visualization and conditional mutations in the erythroid lineage. Blood. 2004; 104(3):659-66. DOI: 10.1182/blood-2003-05-1442. View

Chan G, Kalaitzidis D, Usenko T, Kutok J, Yang W, Mohi M . Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis. Blood. 2009; 113(18):4414-24. PMC: 2676094. DOI: 10.1182/blood-2008-10-182626. View

Tartaglia M, Gelb B, Zenker M . Noonan syndrome and clinically related disorders. Best Pract Res Clin Endocrinol Metab. 2011; 25(1):161-79. PMC: 3058199. DOI: 10.1016/j.beem.2010.09.002. View

Loh M . Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia. Br J Haematol. 2011; 152(6):677-87. DOI: 10.1111/j.1365-2141.2010.08525.x. View

Xu D, Liu X, Yu W, Meyerson H, Guo C, Gerson S . Non-lineage/stage-restricted effects of a gain-of-function mutation in tyrosine phosphatase Ptpn11 (Shp2) on malignant transformation of hematopoietic cells. J Exp Med. 2011; 208(10):1977-88. PMC: 3182060. DOI: 10.1084/jem.20110450. View

Chan G, Cheung L, Yang W, Milyavsky M, Sanders A, Gu S . Essential role for Ptpn11 in survival of hematopoietic stem and progenitor cells. Blood. 2011; 117(16):4253-61. PMC: 3087477. DOI: 10.1182/blood-2010-11-319517. View

Zhang J, Liu Y, Beard C, Tuveson D, Jaenisch R, Jacks T . Expression of oncogenic K-ras from its endogenous promoter leads to a partial block of erythroid differentiation and hyperactivation of cytokine-dependent signaling pathways. Blood. 2007; 109(12):5238-41. PMC: 1890843. DOI: 10.1182/blood-2006-09-047050. View

Braun B, Archard J, Van Ziffle J, Tuveson D, Jacks T, Shannon K . Somatic activation of a conditional KrasG12D allele causes ineffective erythropoiesis in vivo. Blood. 2006; 108(6):2041-4. PMC: 1895533. DOI: 10.1182/blood-2006-01-013490. View

10.

Karur V, Lowell C, Besmer P, Agosti V, Wojchowski D . Lyn kinase promotes erythroblast expansion and late-stage development. Blood. 2006; 108(5):1524-32. PMC: 1895506. DOI: 10.1182/blood-2005-09-008243. View

11.

Zhu H, Ji K, Alderson N, He Z, Li S, Liu W . Kit-Shp2-Kit signaling acts to maintain a functional hematopoietic stem and progenitor cell pool. Blood. 2011; 117(20):5350-61. PMC: 3109710. DOI: 10.1182/blood-2011-01-333476. View

12.

Klingmuller U . The role of tyrosine phosphorylation in proliferation and maturation of erythroid progenitor cells--signals emanating from the erythropoietin receptor. Eur J Biochem. 1997; 249(3):637-47. DOI: 10.1111/j.1432-1033.1997.t01-1-00637.x. View

13.

Chan G, Kalaitzidis D, Neel B . The tyrosine phosphatase Shp2 (PTPN11) in cancer. Cancer Metastasis Rev. 2008; 27(2):179-92. DOI: 10.1007/s10555-008-9126-y. View

14.

Menon M, Fang J, Wojchowski D . Core erythropoietin receptor signals for late erythroblast development. Blood. 2005; 107(7):2662-72. PMC: 1895369. DOI: 10.1182/blood-2005-02-0684. View